Evidence mapPaperPMID 40066272Full record

ReviewFrontiers in microbiology2025

The landscape of biofilm models for phage therapy: mimicking biofilms in diabetic foot ulcers using 3D models.

Mark Grevsen Martinet, Marvin Thomas, Jörg Bojunga, Mathias W Pletz, Maria J G T Vehreschild, Silvia Würstle

Abstract readReview
In one paragraph

Review in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mark Grevsen MartinetInstitute of Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.
Marvin ThomasGoethe University Frankfurt, University Hospital Frankfurt, Department II of Internal Medicine, Infectious Diseases, Frankfurt, Germany.
Jörg BojungaDepartment of Internal Medicine I, Endocrinology and Diabetology, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.
Mathias W PletzInstitute of Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.
Maria J G T VehreschildGoethe University Frankfurt, University Hospital Frankfurt, Department II of Internal Medicine, Infectious Diseases, Frankfurt, Germany.
Silvia WürstleGoethe University Frankfurt, University Hospital Frankfurt, Department II of Internal Medicine, Infectious Diseases, Frankfurt, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic foot ulcers (DFU) affect up to 15-25% of patients suffering from diabetes and are considered a global health concern. These ulcers may result in delayed wound healing and chronic infections, with the potential to lead to amputations. It has been estimated that 85% of diabetes-related amputations are preceded by a diagnosis of DFU. A critical factor in the persistence of this disease is the presence of polymicrobial biofilms, which generally include

Indexed as

3D modelsbacteriophagesbiofilmdiabetic foot ulcersphage therapy

Identifiers

PMID40066272
PMCPMC11891221

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.